Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2025-12-24 @ 2:49 PM
Study NCT ID:
NCT07211659
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-08
First Post:
2025-10-01
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
Sponsor:
Theolytics Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-01
First Submit QC Date:
None
Study First Post Date:
2025-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-01
Last Update Post Date:
2025-10-08
Last Update Post Date Type:
ESTIMATED